Drugs / mRNA coding for melanoma associated antigens
mRNA coding for melanoma associated antigens
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00204516 | Apr 2007 → Aug 2011 | melanoma | University Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA coding for melanoma associated antigens | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00204516 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA vaccine” NCT00204516 ↗ |
| Route | Subcutaneous | “mRNA vaccine s.c. applied weekly” NCT00204516 ↗ |